Goldman Sachs initiated coverage on U.S.-listed generic pharmaceutical companies with Buy ratings on Teva Pharmaceutical Industries (NYSE:TEVA) and Amneal Pharmaceuticals (NASDAQ:AMRX), and a Neutral ...

The recent dismissal of 13 FDA review staff eliminated precisely the kind of government spending that delivered the most bang ...

Pharmaceutical tariffs could increase drug prices and drug shortages, negatively impacting the health care system, experts warn.

Amgen is no exception to this dynamic. Although 2017's Tax Cuts and Jobs Act spurred the company to build a handful of new ...

FDA’s recent focus on potentially harmful color additives in food products has expanded to the pharmaceutical sector. In May ...

We previously reported on an uptick in the passage of state drug price transparency legislation. What follows is an update to that report. As of ...

President Donald J. Trump just released his second executive order (EO) addressing high prescription drug prices. This is ...

Generic drug companies in India are not expected to be affected by US President Donald Trump's new order to bring the prices for prescription (Rx) drugs in line with other developed nations ...

The president said that, because of his executive order, prescription drug prices would be cut “almost immediately.” Here's ...

Another factor is patent exclusivity. Over the years, U.S. pharmaceutical companies have used strong legal protections to ...